TP53 and urinary bladder carcinoma: A significantly higher percentage of bladder cancers with high TMB (65.1%) harbor TP53 mutations compared with the prevalence of 43.8% in the group with low TMB (Fisher’s exact test p < 0.0001, Figure 1).